Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Unveiling the mechanism of dodecylphosphorylcholine as an extremely promising drug delivery system: From self-assembly clusters to drug encapsulation pathways.

Qijiang Shu | Linjing Yang | Li Li | Zedong Lin | Pengru Huang
PloS one | 2025

Significant progress has been achieved in cancer treatment with Doxorubicin (DOX), yet its low toxicity and poor bioavailability have long troubled scientists. Dodecylphosphorylcholine (DPC), as a candidate material for drug delivery systems (DDS), holds promise in assisting DOX to overcome its application bottleneck. In this study, employing a combination of quantum chemical calculations and molecular simulations, we delve into the dynamic processes of the interaction between DPC and DOX molecules for the first time. The results indicate that, under the synergistic effect where electrostatic repulsion plays a minor role and van der Waals attraction predominates, the end (containing choline group) of DPC molecules aggregate, self-assembling into multiple molecular clusters. There is a notable presence of electrostatic attraction and van der Waals attraction between DPC and DOX, which drives the adsorption or encapsulation of DOX molecules by DPC molecular clusters, thus presenting a favorable drug-loading conformation. During these processes, a substantial number of DPC molecules aggregate around DOX, with typical distances for interaction around 0.5 nm. The shape and position of DPC-DOX molecular clusters undergo significant dynamic changes within a simulated time of 0-70 ns, stabilizing thereafter. Our findings elucidate the interaction mechanism between DPC and DOX at the molecular scale, paving new avenues for the experimental synthesis of promising DDS eagerly sought by DOX.

Pubmed ID: 40333930

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PubChem (tool)

RRID:SCR_004284

Collection of information about chemical structures and biological properties of small molecules and siRNA reagents hosted by the National Center for Biotechnology Information (NCBI).

View all literature mentions

ORCA (tool)

RRID:SCR_012097

A Matlab package extending the scope of established COBRA metabolic modelling.

View all literature mentions

GROMACS (tool)

RRID:SCR_014565

A software package created to perform molecular dynamics. It is primarily designed for biochemical molecules like proteins, lipids and nucleic acids that have many complicated bonded interactions, but it can also be used for research on non-biological systems, such as polymers.

View all literature mentions

MOPAC (tool)

RRID:SCR_014898

Software program for semiempirical quantum chemistry for handling of biomolecules.

View all literature mentions